Hide Board Information

Show Board Information

Sifco Industries SIF

Board Mod: Add me as mod

Asst Mods:

Last Post: 12/24/2020 5:17:12 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

1. SIF Company Profile

    

2. SIF Time & Sales

    

3. SIF Recent News

    

4. SIF Filings

    

5. SIF Financials

    

6. SIF Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

2	SIF 35% v23,8M c5.30 f5,9M preMH7.59 HOD6.94 then	znewcar1	12/24/2020 5:17:12 PM
1	SIF 87% v17,5M c4.14 f5,8M H5.5 gap +GO then	znewcar1	05/13/2020 4:16:27 PM

Recent Articles

• Adagene to Showcase Innovative Cancer Treatments at Summit
• Vaxart Announces Important Updates and Conference Call Details
• Explore Superior Group's Upcoming Investor Conference Events
• NKGen Biotech's Groundbreaking Troculeucel Presentation Insights
• Dominion Lending Centres Inc. Prepares for Earnings Release Announcement
• Polyrizon Innovates with Intranasal Naloxone for Opioid Crisis
• BIO-key Forms Partnership to Transform School Authentication
• NV5 Expands Its Data Center Capabilities with New Acquisition
• Verde Resources Achieves Major Carbon Reduction in Roadworks
• CIFF Guangzhou 2025: Pioneering Global Design Trends
• TransCode Therapeutics Advances Innovative Cancer Treatments
• Lip-Bu Tan Takes the Helm at Intel: A New Era Begins
• Exploring the Rising Trends in the Cloud MES Market Growth
• Strategic Progress for Jeffs' Brands Amid Planned Merger
• VITAS Healthcare's Dr. Sandhya Bhalla Recognized as Fellow
• ZenaTech Boosts Workforce to Meet Growing Drone Production Demand
• Creative Realities, Inc.'s 2024 Earnings Call and Insights
• Quoin Pharmaceuticals' Remarkable Growth in 2024 Highlights
• Amy Gilliland Joins Rett Syndrome Research Trust's Board
• Knight Therapeutics to Discuss Year-End Results for 2024
• Dragonfly Energy to Share Key Financial Results Soon
• Creative Realities, Inc. Unveils Upcoming Earnings Call Details
• Knight Therapeutics to Discuss 2024 Financial Results on Call
• Indaptus Therapeutics Shows Promising Trial Progress and Growth
• MeiraGTx Partners with Hologen AI for Advancing Parkinson's Treatment
• Tourmaline Bio's Promising Developments in Clinical Trials
• PDD Holdings Prepares to Reveal Q4 and Annual Results
• MeiraGTx Speeding Phase 3 Development with Hologen AI Partnership
• Michael Herde Joins FTI Consulting to Transform Financial Services
• Trinity Biotech Expands Strategic Focus on CGM Technology
• Dragonfly Energy Unveils Upcoming Q4 2024 Financial Results
• MIRA Pharmaceuticals Unveils New Topical Treatment for Pain Relief
• PDD Holdings Set to Announce Fourth Quarter Financial Results
• FTI Consulting Welcomes New Senior Managing Director
• Verde Resources Revolutionizes Road Construction with Tech
• Altisource Reports Impressive Fourth Quarter and Yearly Gains
• Quoin Pharmaceuticals Achieves Key Milestones While Reporting 2024 Results
• Advanced Flower Capital Inc. Reveals 2024 Year-End Financials
• Tourmaline Bio Unveils Promising Financial Results and Highlights
• Understanding Alliance Witan PLC’s Net Asset Value Adjustments
• Indaptus Therapeutics: Significant Milestones and Future Prospects
• Ballard Power Systems Reports Challenging Q4 Results
• AMSURG's New Values Enhance Patient-Centric Culture
• Altisource Surpasses Revenue Expectations in 2024
• Gentoo Media Shareholders Decide on Euronext Delisting Move
• Danaos Corporation's 2024 Annual Report Now Available for Review
• Advanced Flower Capital Reports 2024 Year-End Financials
• India Giving Day: A Call to Action for Philanthropy Growth
• Phoenix Financial Reports Strong 2024 Financial Results
• Virax Biolabs Unveils Findings on T-Cell Dysfunction at Conference